Dianthus Therapeutics, Inc.
US ˙ NasdaqCM ˙ US2528281080

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Alphabet Inc.. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Alphabet Inc. telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
10% Owner 3,262,440
US:VERV / Verve Therapeutics, Inc. 10% Owner 0
US:STCB / Starco Brands, Inc. 10% Owner 147,490,961
US:FRSH / Freshworks Inc. 10% Owner 1,941,391
US:OSCR / Oscar Health, Inc. 10% Owner 0
US:GTLB / GitLab Inc. 2,647,312
US:DUOL / Duolingo, Inc. 10% Owner 578,755
10% Owner 0
10% Owner 31,942,641
US:CRWD / CrowdStrike Holdings, Inc. 10% Owner 1,137,641
US:CRCM / Care.com, Inc. 10% Owner 46,350
US:MGTA / Magenta Therapeutics Inc 10% Owner 0
US:RCUS / Arcus Biosciences, Inc. 10% Owner 0
US:ARMO / ARMO BioSciences, Inc. 10% Owner 0
US:ASNS / Actelis Networks, Inc. 10% Owner 0
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Alphabet Inc.. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam DNTH / Dianthus Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di DNTH / Dianthus Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

DNTH / Dianthus Therapeutics, Inc. Insider Trades
Penjualan Orang Dalam DNTH / Dianthus Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di DNTH / Dianthus Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

DNTH / Dianthus Therapeutics, Inc. Insider Trades
Pembelian Orang Dalam GTLB / GitLab Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di DNTH / Dianthus Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2023-05-05 GTLB GV 2021 GP, L.L.C. 7,286 26.9810 7,286 26.9810 196,584 280 77.6000 368,811 187.61
2023-05-04 GTLB GV 2021 GP, L.L.C. 302,483 26.7533 302,483 26.7533 8,092,418
2023-05-04 GTLB GV 2021 GP, L.L.C. 91,710 27.6522 91,710 27.6522 2,535,983
2023-05-04 GTLB GV 2021 GP, L.L.C. 2,168 28.2580 2,168 28.2580 61,263
2023-05-03 GTLB GV 2021 GP, L.L.C. 287,470 28.2952 287,470 28.2952 8,134,021
2023-05-03 GTLB GV 2021 GP, L.L.C. 22,461 28.9527 22,461 28.9527 650,307
2023-03-14 GTLB GV 2021 GP, L.L.C. 169,156 30.3030 169,156 30.3030 5,125,934
2023-03-14 GTLB GV 2021 GP, L.L.C. 55,051 30.9678 55,051 30.9678 1,704,808
2023-03-13 GTLB GV 2021 GP, L.L.C. 119,798 28.2554 119,798 28.2554 3,384,940
2023-03-13 GTLB GV 2021 GP, L.L.C. 152,251 29.1180 152,251 29.1180 4,433,245
2023-03-13 GTLB GV 2021 GP, L.L.C. 126,938 30.2739 126,938 30.2739 3,842,908
2023-03-13 GTLB GV 2021 GP, L.L.C. 16,013 30.9942 16,013 30.9942 496,310
2022-11-09 GTLB GV 2021 GP, L.L.C. 128,911 34.2931 128,911 34.2931 4,420,758
2022-11-09 GTLB GV 2021 GP, L.L.C. 42,833 35.1508 42,833 35.1508 1,505,614
2022-11-09 GTLB GV 2021 GP, L.L.C. 10,568 36.0939 10,568 36.0939 381,440
2022-11-08 GTLB GV 2021 GP, L.L.C. 14,264 35.9663 14,264 35.9663 513,023
2022-11-08 GTLB GV 2021 GP, L.L.C. 25,159 36.3752 25,159 36.3752 915,164
2022-11-07 GTLB GV 2021 GP, L.L.C. 136,376 34.9056 136,376 34.9056 4,760,286
2022-11-07 GTLB GV 2021 GP, L.L.C. 65,421 35.6900 65,421 35.6900 2,334,875
2022-11-07 GTLB GV 2021 GP, L.L.C. 100 36.4100 100 36.4100 3,641
2022-11-04 GTLB GV 2021 GP, L.L.C. 121,424 35.5257 121,424 35.5257 4,313,673
2022-11-04 GTLB GV 2021 GP, L.L.C. 141,028 36.2899 141,028 36.2899 5,117,892
2022-11-04 GTLB GV 2021 GP, L.L.C. 15,041 37.2111 15,041 37.2111 559,692
2022-05-24 GTLB GV 2021 GP, L.L.C. 13,528 33.7189 13,528 33.7189 456,149
2022-05-12 GTLB GV 2021 GP, L.L.C. 14,860 32.9636 14,860 32.9636 489,839
2022-05-12 GTLB GV 2021 GP, L.L.C. 9,183 33.7340 9,183 33.7340 309,779
2022-05-11 GTLB GV 2021 GP, L.L.C. 76,136 34.7095 76,136 34.7095 2,642,642
2022-05-10 GTLB GV 2021 GP, L.L.C. 82,055 33.7184 82,055 33.7184 2,766,763
2022-05-10 GTLB GV 2021 GP, L.L.C. 77,391 34.4586 77,391 34.4586 2,666,786
2022-05-10 GTLB GV 2021 GP, L.L.C. 80,488 35.4065 80,488 35.4065 2,849,798
2022-05-10 GTLB GV 2021 GP, L.L.C. 15,513 36.5711 15,513 36.5711 567,327
2022-05-10 GTLB GV 2021 GP, L.L.C. 200 37.0000 200 37.0000 7,400

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

GTLB / GitLab Inc. Insider Trades
Penjualan Orang Dalam GTLB / GitLab Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di DNTH / Dianthus Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

GTLB / GitLab Inc. Insider Trades
Pembelian Orang Dalam OSCR / Oscar Health, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di DNTH / Dianthus Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

OSCR / Oscar Health, Inc. Insider Trades
Penjualan Orang Dalam OSCR / Oscar Health, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di DNTH / Dianthus Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2023-08-17 OSCR Alphabet Inc. 5,719,438 8.0810 5,719,438 8.0810 46,218,778 70 4.8500 -18,479,504 -39.98
2023-08-17 OSCR Alphabet Inc. 525,470 8.0810 525,470 8.0810 4,246,323
2023-08-17 OSCR Alphabet Inc. 255,092 8.0810 255,092 8.0810 2,061,398

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

OSCR / Oscar Health, Inc. Insider Trades
Pembelian Orang Dalam RCUS / Arcus Biosciences, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di DNTH / Dianthus Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

RCUS / Arcus Biosciences, Inc. Insider Trades
Penjualan Orang Dalam RCUS / Arcus Biosciences, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di DNTH / Dianthus Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

RCUS / Arcus Biosciences, Inc. Insider Trades
Pembelian Orang Dalam STCB / Starco Brands, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di DNTH / Dianthus Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

STCB / Starco Brands, Inc. Insider Trades
Penjualan Orang Dalam STCB / Starco Brands, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di DNTH / Dianthus Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

STCB / Starco Brands, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Alphabet Inc. sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-08-05 2025-08-01 4 PRME Prime Medicine, Inc.
Common Stock
P - Purchase 1,500,000 3,262,440 85.11 3.30 4,950,000 10,766,052
2025-07-28 2025-07-25 4 VERV Verve Therapeutics, Inc.
Common Stock
U - Other -1,800,000 0 -100.00
2025-07-28 2025-07-25 4 VERV Verve Therapeutics, Inc.
Common Stock
U - Other -4,260,047 0 -100.00
2025-07-28 2025-07-25 4 VERV Verve Therapeutics, Inc.
Common Stock
U - Other -6,108,442 0 -100.00
2025-05-19 2025-05-15 4 STCB Starco Brands, Inc.
Class A Common Stock
J - Other 47,980,156 147,490,961 48.22
2025-02-13 2024-02-15 4 STCB Starco Brands, Inc.
Class A Common Stock
J - Other 36,300,393 99,510,805 57.43
2025-02-13 2024-02-14 4 STCB Starco Brands, Inc.
Class A Common Stock
J - Other 5,675,399 63,210,412 9.86
2024-08-30 3 FRSH Freshworks Inc.
Class A Common Stock
1,941,391
2024-08-30 3 FRSH Freshworks Inc.
Class A Common Stock
1,879,370
2024-08-30 3 FRSH Freshworks Inc.
Class A Common Stock
4,726,247
2024-08-30 3 FRSH Freshworks Inc.
Class A Common Stock
3,789,635
2024-08-30 3 FRSH Freshworks Inc.
Class A Common Stock
3,870,000
2024-02-29 3 PRME Prime Medicine, Inc.
Common Stock
3,200,000
2023-12-05 3 VERV Verve Therapeutics, Inc.
Common Stock
1,800,000
2023-08-21 2023-08-17 4 OSCR Oscar Health, Inc.
Class A Common Stock
S - Sale -255,092 0 -100.00 8.08 -2,061,398
2023-08-21 2023-08-17 4 OSCR Oscar Health, Inc.
Class A Common Stock
S - Sale -525,470 1,180,474 -30.80 8.08 -4,246,323 9,539,410
2023-08-21 2023-08-17 4 OSCR Oscar Health, Inc.
Class A Common Stock
S - Sale -5,719,438 15,625,310 -26.80 8.08 -46,218,778 126,268,130
2023-06-22 2023-06-21 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -19,003 0 -100.00 14.97 -284,496
2023-06-22 2023-06-21 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -19,003 10,100,058 -0.19
2023-06-22 2023-06-20 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -37,405 0 -100.00 15.06 -563,248
2023-06-22 2023-06-20 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -37,405 10,119,061 -0.37
2023-06-20 2023-06-16 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -6,532 0 -100.00 15.02 -98,109
2023-06-20 2023-06-16 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -6,532 10,156,466 -0.06
2023-06-20 2023-06-15 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -66,659 0 -100.00 14.92 -994,326
2023-06-20 2023-06-15 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -66,659 10,162,998 -0.65
2023-06-15 2023-06-14 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -28,960 0 -100.00 14.87 -430,684
2023-06-15 2023-06-14 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -28,960 10,229,657 -0.28
2023-06-15 2023-06-13 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -28,100 0 -100.00 15.13 -425,102
2023-06-15 2023-06-13 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -28,100 10,258,617 -0.27
2023-06-13 2023-06-12 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -16,031 0 -100.00 14.98 -240,151
2023-06-13 2023-06-12 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -16,031 10,286,717 -0.16
2023-06-13 2023-06-09 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -15,672 0 -100.00 14.48 -226,984
2023-06-13 2023-06-09 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -15,672 10,302,748 -0.15
2023-06-09 2023-06-08 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -5,000 0 -100.00 15.74 -78,686
2023-06-09 2023-06-08 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -5,000 10,318,420 -0.05
2023-06-09 2023-06-07 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -15,000 0 -100.00 16.92 -253,870
2023-06-09 2023-06-07 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -15,000 10,323,420 -0.15
2023-06-07 2023-06-06 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -29,975 0 -100.00 17.02 -510,166
2023-06-07 2023-06-06 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -29,975 10,338,420 -0.29
2023-06-07 2023-06-05 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -22,434 0 -100.00 16.70 -374,612
2023-06-07 2023-06-05 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -22,434 10,368,395 -0.22
2023-06-02 2023-06-01 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -471 0 -100.00 14.75 -6,949
2023-06-02 2023-06-01 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -44,752 471 -98.96 14.35 -642,245 6,759
2023-06-02 2023-06-01 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -45,223 10,390,829 -0.43
2023-06-02 2023-05-31 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -16,633 0 -100.00 13.65 -227,004
2023-06-02 2023-05-31 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -16,633 10,436,052 -0.16
2023-05-31 2023-05-30 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -16,805 0 -100.00 13.70 -230,240
2023-05-31 2023-05-30 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -16,805 10,452,685 -0.16
2023-05-31 2023-05-26 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -12,602 0 -100.00 13.70 -172,603
2023-05-31 2023-05-26 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -12,602 10,469,490 -0.12
2023-05-26 2023-05-25 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -23,161 0 -100.00 13.38 -309,973
2023-05-26 2023-05-25 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -23,161 10,482,092 -0.22
2023-05-26 2023-05-24 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -7,900 0 -100.00 13.66 -107,920
2023-05-26 2023-05-24 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -7,900 10,505,253 -0.08
2023-05-24 2023-05-23 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -43,939 0 -100.00 14.74 -647,648
2023-05-24 2023-05-23 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -43,939 10,513,153 -0.42
2023-05-24 2023-05-22 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -87,922 0 -100.00 14.13 -1,242,092
2023-05-24 2023-05-22 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -87,922 10,557,092 -0.83
2023-05-22 2023-05-19 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -63,212 0 -100.00 13.88 -877,066
2023-05-22 2023-05-19 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -63,212 10,645,014 -0.59
2023-05-22 2023-05-18 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -14,022 0 -100.00 13.06 -183,171
2023-05-22 2023-05-18 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -14,022 10,708,226 -0.13
2023-05-22 2023-05-18 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -13,076 10,722,248 -0.12 13.01 -170,100 139,481,435
2023-05-18 2023-05-17 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -15,000 10,735,324 -0.14 12.77 -191,600 137,125,514
2023-05-18 2023-05-16 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -50,649 10,750,324 -0.47 12.59 -637,676 135,347,654
2023-05-16 2023-05-15 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -157,952 10,800,973 -1.44 12.74 -2,012,087 137,589,275
2023-05-16 2023-05-12 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -27,290 10,958,925 -0.25 12.72 -347,222 139,434,786
2023-05-12 2023-05-11 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -4,807 10,986,215 -0.04 13.79 -66,290 151,503,201
2023-05-12 2023-05-11 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -21,819 10,991,022 -0.20 12.98 -283,243 142,679,952
2023-05-12 2023-05-10 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -87,397 11,012,841 -0.79 14.03 -1,225,804 154,462,804
2023-05-10 2023-05-09 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -321,238 11,100,238 -2.81 14.08 -4,522,613 156,276,921
2023-05-10 2023-05-08 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -100,772 11,421,476 -0.87 14.13 -1,423,727 161,364,897
2023-05-09 2023-05-05 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 7,286 2,647,312 0.28 26.98 196,584 71,427,125
2023-05-05 2023-05-04 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 2,168 2,640,026 0.08 28.26 61,263 74,601,855
2023-05-05 2023-05-04 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 91,710 2,637,858 3.60 27.65 2,535,983 72,942,577
2023-05-05 2023-05-04 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 302,483 2,546,148 13.48 26.75 8,092,418 68,117,861
2023-05-05 2023-05-03 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 22,461 2,243,665 1.01 28.95 650,307 64,960,160
2023-05-05 2023-05-03 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 287,470 2,221,204 14.87 28.30 8,134,021 62,849,411
2023-03-15 2023-03-14 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 55,051 1,933,734 2.93 30.97 1,704,808 59,883,488
2023-03-15 2023-03-14 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 169,156 1,878,683 9.89 30.30 5,125,934 56,929,731
2023-03-15 2023-03-13 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 16,013 1,709,527 0.95 30.99 496,310 52,985,422
2023-03-15 2023-03-13 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 126,938 1,693,514 8.10 30.27 3,842,908 51,269,273
2023-03-15 2023-03-13 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 152,251 1,566,576 10.76 29.12 4,433,245 45,615,560
2023-03-15 2023-03-13 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 119,798 1,414,325 9.25 28.26 3,384,940 39,962,319
2023-02-27 3 STCB Starco Brands, Inc.
Class A Common Stock
57,535,013
2022-11-10 2022-11-09 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 10,568 1,294,527 0.82 36.09 381,440 46,724,528
2022-11-10 2022-11-09 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 42,833 1,283,959 3.45 35.15 1,505,614 45,132,186
2022-11-10 2022-11-09 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 128,911 1,241,126 11.59 34.29 4,420,758 42,562,058
2022-11-10 2022-11-08 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 25,159 1,112,215 2.31 36.38 915,164 40,457,043
2022-11-10 2022-11-08 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 14,264 1,087,056 1.33 35.97 513,023 39,097,382
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -243 4,260,047 -0.01 32.90 -7,995 140,155,546
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -650 4,260,290 -0.02 31.99 -20,794 136,288,807
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -47,690 4,260,940 -1.11 31.12 -1,484,017 132,591,931
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -47,690 4,260,940 -1.11 31.12 -1,484,017 132,591,931
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -242 0 -100.00 32.90 -7,962
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -651 242 -72.90 31.99 -20,826 7,742
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
J - Other -48,583 6,108,442 -0.79
2022-11-08 2022-11-07 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 100 1,072,792 0.01 36.41 3,641 39,060,357
2022-11-08 2022-11-07 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 65,421 1,072,692 6.49 35.69 2,334,875 38,284,377
2022-11-08 2022-11-07 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 136,376 1,007,271 15.66 34.91 4,760,286 35,159,399
2022-11-08 2022-11-04 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 15,041 870,895 1.76 37.21 559,692 32,406,961
2022-11-08 2022-11-04 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 141,028 855,854 19.73 36.29 5,117,892 31,058,856
2022-11-08 2022-11-04 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 121,424 714,826 20.46 35.53 4,313,673 25,394,694
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -1,755 4,308,630 -0.04 33.84 -59,384 145,792,406
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -1,755 4,308,630 -0.04 33.84 -59,384 145,792,406
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -25,534 4,310,385 -0.59 33.14 -846,156 142,839,262
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -22,279 4,335,919 -0.51 32.32 -719,957 140,117,390
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -22,279 4,335,919 -0.51 32.32 -719,957 140,117,390
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -25,535 1,755 -93.57 33.14 -846,189 58,158
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
J - Other -49,569 6,157,025 -0.80
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -8,930 4,358,198 -0.20 36.78 -328,401 160,272,731
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -8,930 4,358,198 -0.20 36.78 -328,401 160,272,731
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -10,372 4,367,128 -0.24 36.28 -376,282 158,433,290
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -10,372 4,367,128 -0.24 36.28 -376,282 158,433,290
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -9,350 4,377,500 -0.21 34.78 -325,150 152,229,314
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -9,349 19,302 -32.63 34.78 -325,115 671,235
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
J - Other -28,651 6,206,594 -0.46
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -260 4,386,850 -0.01 38.64 -10,046 169,501,304
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -260 4,386,850 -0.01 38.64 -10,046 169,501,304
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -2,377 4,387,110 -0.05 37.82 -89,901 165,924,887
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -2,377 4,387,110 -0.05 37.82 -89,901 165,924,887
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -29,326 4,389,487 -0.66 36.69 -1,075,906 161,040,621
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -29,326 4,389,487 -0.66 36.69 -1,075,906 161,040,621
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
J - Other -31,963 6,235,245 -0.51
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -88 4,418,813 0.00 40.64 -3,577 179,600,445
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -88 4,418,813 0.00 40.64 -3,577 179,600,445
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -6,601 4,418,901 -0.15 40.16 -265,076 177,449,366
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -6,601 4,418,901 -0.15 40.16 -265,076 177,449,366
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -23,275 4,425,502 -0.52 38.94 -906,403 172,343,209
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -23,732 4,448,777 -0.53 37.91 -899,588 168,635,786
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -23,732 4,448,777 -0.53 37.91 -899,588 168,635,786
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -23,276 6,689 -77.68 38.94 -906,442 260,491
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
J - Other -53,697 6,267,208 -0.85
2022-10-26 2022-10-24 4 PRME Prime Medicine, Inc.
Common Stock
P - Purchase 800,000 11,522,248 7.46 17.00 13,600,000 195,878,216
2022-10-26 2022-10-24 4 PRME Prime Medicine, Inc.
Common Stock
C - Conversion 1,762,440 1,762,440
2022-10-26 2022-10-24 4 PRME Prime Medicine, Inc.
Common Stock
C - Conversion 10,722,248 10,722,248
2022-07-15 2022-07-13 4 DUOL Duolingo, Inc.
Class A Common Stock
C - Conversion 500,000 578,755 634.88
2022-05-25 2022-05-24 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 13,528 593,402 2.33 33.72 456,149 20,008,863
2022-05-16 2022-05-12 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 9,183 579,874 1.61 33.73 309,779 19,561,470
2022-05-16 2022-05-12 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 14,860 570,691 2.67 32.96 489,839 18,812,030
2022-05-12 3 GTLB Gitlab Inc.
Class A Common Stock
224,048
2022-05-12 2022-05-11 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 76,136 555,831 15.87 34.71 2,642,642 19,292,616
2022-05-12 2022-05-10 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 200 479,695 0.04 37.00 7,400 17,748,715
2022-05-12 2022-05-10 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 15,513 479,495 3.34 36.57 567,327 17,535,660
2022-05-12 2022-05-10 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 80,488 463,982 20.99 35.41 2,849,798 16,427,979
2022-05-12 2022-05-10 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 77,391 383,494 25.28 34.46 2,666,786 13,214,666
2022-05-12 2022-05-10 4 GTLB Gitlab Inc.
Class A Common Stock
P - Purchase 82,055 306,103 36.62 33.72 2,766,763 10,321,303
2022-05-06 2021-10-18 4 GTLB Gitlab Inc.
Series D Preferred Stock
C - Conversion -514,736 0 -100.00
2022-05-06 2021-10-18 4 GTLB Gitlab Inc.
Series C Preferred Stock
C - Conversion -8,374,040 0 -100.00
2022-05-06 2021-10-18 4 GTLB Gitlab Inc.
Class B Common Stock
C - Conversion 8,888,776 8,888,776
2022-04-12 2022-04-11 4 IONQ IonQ, Inc.
Common Stock
S - Sale -4,992 0 -100.00 11.83 -59,046
2022-04-12 2022-04-11 4 IONQ IonQ, Inc.
Common Stock
S - Sale -539,257 4,992 -99.08 11.16 -6,015,412 55,686
2022-04-12 2022-04-11 4 IONQ IonQ, Inc.
Common Stock
J - Other -2,642,573 14,707,933 -15.23
2022-04-08 3/A IONQ IonQ, Inc.
Common Stock
17,350,506
2022-04-08 3/A IONQ IonQ, Inc.
Common Stock
4,556,532
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -90 270,303 -0.03 151.01 -13,591 40,818,456
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -110 324,059 -0.03 151.01 -16,611 48,936,150
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -91 270,393 -0.03 150.16 -13,665 40,602,213
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -109 324,169 -0.03 150.16 -16,367 48,677,217
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -955 270,484 -0.35 148.64 -141,951 40,204,742
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,145 324,278 -0.35 148.64 -170,193 48,200,682
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,684 271,439 -0.62 147.63 -248,609 40,072,540
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,019 325,423 -0.62 147.63 -298,065 48,042,197
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -7,186 273,123 -2.56 146.55 -1,053,108 40,026,176
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -8,615 327,442 -2.56 146.55 -1,262,528 47,986,625
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -12,965 280,309 -4.42 145.95 -1,892,242 40,911,099
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -15,543 336,057 -4.42 145.95 -2,268,501 49,047,519
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,483 293,274 -0.50 144.74 -214,649 42,448,479
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,777 351,600 -0.50 144.74 -257,203 50,890,584
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,547 294,757 -0.52 143.29 -221,670 42,235,731
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,854 353,377 -0.52 143.29 -265,660 50,635,390
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,274 296,304 -0.76 142.51 -324,068 42,226,283
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,726 355,231 -0.76 142.51 -388,482 50,623,970
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -3,927 298,578 -1.30 141.28 -554,807 42,183,100
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -4,709 357,957 -1.30 141.28 -665,288 50,572,165
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -10,316 302,505 -3.30 140.33 -1,447,644 42,450,527
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -12,368 362,666 -3.30 140.33 -1,735,601 50,892,920
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -4,825 312,821 -1.52 139.30 -672,122 43,575,965
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -5,784 375,034 -1.52 139.30 -805,711 52,242,236
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -6,294 317,646 -1.94 138.30 -870,460 43,930,442
2022-02-10 2021-11-15 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -7,546 380,818 -1.94 138.30 -1,043,612 52,667,129
2022-02-10 2021-11-04 4 DUOL Duolingo, Inc.
Class B Common Stock
C - Conversion -323,940 789,001 -29.11
2022-02-10 2021-11-04 4 DUOL Duolingo, Inc.
Class B Common Stock
C - Conversion -388,364 945,920 -29.11
2022-02-10 2021-11-04 4 DUOL Duolingo, Inc.
Class A Common Stock
C - Conversion 323,940 323,940
2022-02-10 2021-11-04 4 DUOL Duolingo, Inc.
Class A Common Stock
C - Conversion 388,364 388,364
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,182 253,356 -0.46 140.55 -166,130 35,609,186
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,418 303,742 -0.46 140.55 -199,300 42,690,938
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -5,894 254,538 -2.26 139.87 -824,394 35,602,230
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -7,067 305,160 -2.26 139.87 -988,461 42,682,729
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -4,277 260,432 -1.62 138.88 -593,990 36,168,796
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -5,128 312,227 -1.62 138.88 -712,177 43,362,086
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -74 264,709 -0.03 137.36 -10,165 36,360,428
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -88 317,355 -0.03 137.36 -12,088 43,591,883
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,060 264,783 -0.77 136.41 -281,005 36,119,049
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,469 317,443 -0.77 136.41 -336,796 43,302,400
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,060 268,243 -0.76 135.63 -279,398 36,381,798
2022-02-10 2021-11-16 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,469 321,590 -0.76 135.63 -334,870 43,617,252
2022-02-10 2021-11-18 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,219 206,364 -1.06 138.18 -306,621 28,515,378
2022-02-10 2021-11-18 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,660 247,404 -1.06 138.18 -367,559 34,186,285
2022-02-10 2021-11-18 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -7,460 208,583 -3.45 137.58 -1,026,347 28,696,849
2022-02-10 2021-11-18 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -8,944 250,064 -3.45 137.58 -1,230,516 34,403,805
2022-02-10 2021-11-18 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -4,051 216,043 -1.84 136.67 -553,650 29,526,597
2022-02-10 2021-11-18 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -4,857 259,008 -1.84 136.67 -663,806 35,398,623
2022-02-10 2021-11-18 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -3,743 220,094 -1.67 135.66 -507,775 29,857,952
2022-02-10 2021-11-18 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -4,487 263,865 -1.67 135.66 -608,706 35,795,926
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -500 223,837 -0.22 144.96 -72,480 32,447,412
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -600 268,352 -0.22 144.96 -86,976 38,900,306
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -799 224,337 -0.35 144.35 -115,336 32,383,046
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -957 268,952 -0.35 144.35 -138,143 38,823,221
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -3,850 225,136 -1.68 143.18 -551,243 32,234,972
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -4,615 269,909 -1.68 143.18 -660,776 38,645,571
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -16,193 228,986 -6.60 142.34 -2,304,912 32,593,867
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -19,414 274,524 -6.60 142.34 -2,763,389 39,075,746
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -5,879 245,179 -2.34 14.53 -85,422 3,562,451
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -7,049 293,938 -2.34 141.53 -997,645 41,601,045
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -427 251,058 -0.17 140.30 -59,908 35,223,437
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -511 300,987 -0.17 140.30 -71,693 42,228,476
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -825 251,485 -0.33 139.17 -114,815 34,999,167
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -990 301,498 -0.33 139.17 -137,778 41,959,477
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -864 252,310 -0.34 138.28 -119,474 34,889,427
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,036 302,488 -0.34 138.28 -143,258 41,828,041
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -182 253,174 -0.07 136.99 -24,932 34,682,306
2022-02-10 2021-11-17 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -218 303,524 -0.07 136.99 -29,864 41,579,753
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -90 137,258 -0.07 135.90 -12,231 18,653,362
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -110 164,556 -0.07 135.90 -14,949 22,363,160
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -96 137,348 -0.07 134.83 -12,944 18,518,631
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -115 164,666 -0.07 134.83 -15,505 22,201,917
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -29,274 137,444 -17.56 133.93 -3,920,667 18,407,875
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -35,094 164,781 -17.56 133.93 -4,700,139 22,069,119
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -7,990 166,718 -4.57 132.62 -1,059,634 22,110,141
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -9,578 199,875 -4.57 132.62 -1,270,234 26,507,422
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -16,270 174,708 -8.52 131.55 -2,140,318 22,982,837
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -19,505 209,453 -8.52 131.55 -2,565,883 27,553,542
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,046 190,978 -0.54 130.82 -136,838 24,983,742
2022-02-10 2021-11-22 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,254 228,958 -0.54 130.82 -164,048 29,952,286
2022-02-10 2021-11-19 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -99 192,024 -0.05 136.59 -13,522 26,228,558
2022-02-10 2021-11-19 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -120 230,212 -0.05 136.59 -16,391 31,444,657
2022-02-10 2021-11-19 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -3,574 192,123 -1.83 135.99 -486,028 26,126,807
2022-02-10 2021-11-19 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -4,284 230,332 -1.83 135.99 -582,581 31,322,849
2022-02-10 2021-11-19 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,941 195,697 -0.98 134.67 -261,394 26,354,515
2022-02-10 2021-11-19 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,327 236,616 -0.97 134.67 -313,377 31,865,077
2022-02-10 2021-11-19 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -6,277 197,638 -3.08 133.87 -840,302 26,457,799
2022-02-10 2021-11-19 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -7,526 236,943 -3.08 133.87 -1,007,506 31,719,559
2022-02-10 2021-11-19 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,449 203,915 -1.19 133.01 -325,741 27,122,734
2022-02-10 2021-11-19 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,935 244,469 -1.19 133.01 -390,384 32,516,822
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,929 105,379 -1.80 136.98 -264,234 14,434,815
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,312 126,337 -1.80 136.98 -316,698 17,305,642
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -4,313 107,308 -3.86 136.11 -587,042 14,605,692
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -5,171 128,649 -3.86 136.11 -703,825 17,510,415
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -773 111,621 -0.69 135.37 -104,641 15,110,135
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -927 133,820 -0.69 135.37 -125,488 18,115,213
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,046 112,394 -0.92 133.98 -140,143 15,058,548
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,254 134,747 -0.92 133.98 -168,011 18,053,403
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,115 113,440 -0.97 132.82 -148,094 15,067,101
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,337 136,001 -0.97 132.82 -177,580 18,063,653
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -22,703 114,555 -16.54 132.27 -3,002,926 15,152,190
2022-02-10 2021-11-23 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -27,218 137,338 -16.54 132.27 -3,600,125 18,165,697
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -94 88,528 -0.11 135.42 -12,729 11,988,462
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -106 106,135 -0.10 135.42 -14,355 14,372,802
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -45 88,622 -0.05 134.25 -6,041 11,897,504
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -55 106,241 -0.05 134.25 -7,384 14,262,854
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -45 88,667 -0.05 133.07 -5,988 11,798,918
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -55 106,296 -0.05 133.07 -7,319 14,144,809
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -136 88,712 -0.15 132.10 -17,966 11,718,855
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -164 106,351 -0.15 132.10 -21,664 14,048,967
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -46 88,848 -0.05 131.00 -6,026 11,639,088
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -55 106,515 -0.05 131.00 -7,205 13,953,465
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -458 88,894 -0.51 130.31 -59,682 11,583,777
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -550 106,570 -0.51 130.31 -71,670 13,887,137
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -318 89,352 -0.35 129.08 -41,047 11,533,556
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -382 107,120 -0.36 129.08 -49,309 13,827,050
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -500 89,670 -0.55 127.89 -63,945 11,467,896
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -600 107,502 -0.56 127.89 -76,734 13,748,431
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -637 90,170 -0.70 127.00 -80,899 11,451,590
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -763 108,102 -0.70 127.00 -96,901 13,728,954
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -386 90,807 -0.42 125.17 -48,316 11,366,312
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -463 108,865 -0.42 125.17 -57,954 13,626,632
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -372 91,193 -0.41 124.11 -46,169 11,317,963
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -446 109,328 -0.41 124.11 -55,353 13,568,698
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -3,717 91,565 -3.90 123.33 -458,418 11,292,711
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -4,456 109,774 -3.90 123.33 -549,558 13,538,427
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,077 95,282 -2.13 122.49 -254,412 11,671,092
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,491 114,230 -2.13 122.49 -305,123 13,992,033
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,287 97,359 -2.30 121.57 -278,031 11,835,934
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,742 116,721 -2.30 121.57 -333,345 14,189,772
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -5,733 99,646 -5.44 120.37 -690,081 11,994,389
2022-02-10 2021-11-24 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -6,874 119,463 -5.44 120.37 -827,423 14,379,761
2022-02-10 2021-11-29 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -136 65,689 -0.21 123.69 -16,822 8,125,072
2022-02-10 2021-11-29 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -164 78,755 -0.21 123.69 -20,285 9,741,206
2022-02-10 2021-11-29 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,415 65,825 -2.10 122.38 -173,168 8,055,664
2022-02-10 2021-11-29 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,696 78,919 -2.10 122.38 -207,556 9,658,107
2022-02-10 2021-11-29 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -5,935 67,240 -8.11 121.50 -721,102 8,169,660
2022-02-10 2021-11-29 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -7,114 80,615 -8.11 121.50 -864,351 9,794,722
2022-02-10 2021-11-29 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -5,356 73,175 -6.82 120.44 -645,077 8,813,197
2022-02-10 2021-11-29 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -6,421 87,729 -6.82 120.44 -773,345 10,566,081
2022-02-10 2021-11-26 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -910 78,531 -1.15 124.56 -113,350 9,781,821
2022-02-10 2021-11-26 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,092 94,150 -1.15 124.56 -136,020 11,727,324
2022-02-10 2021-11-26 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -970 79,441 -1.21 123.42 -119,717 9,804,608
2022-02-10 2021-11-26 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,162 95,242 -1.21 123.42 -143,414 11,754,768
2022-02-10 2021-11-26 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -4,596 80,411 -5.41 122.52 -563,102 9,851,956
2022-02-10 2021-11-26 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -5,510 96,404 -5.41 122.52 -675,085 11,811,418
2022-02-10 2021-11-26 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,967 85,007 -2.26 121.48 -238,951 10,326,650
2022-02-10 2021-11-26 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -2,359 101,914 -2.26 121.48 -286,571 12,380,513
2022-02-10 2021-11-26 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,554 86,974 -1.76 120.46 -187,195 10,476,888
2022-02-10 2021-11-26 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale X -1,862 104,273 -1.75 120.46 -224,297 12,560,726
2021-12-17 3 PL Planet Labs PBC
Class A Common Stock
31,942,641
2021-11-23 2021-11-22 4 FRSH Freshworks Inc.
Class A Common Stock
S - Sale -1,319 2,094,204 -0.06 37.91 -50,003 79,391,274
2021-11-23 2021-11-22 4 FRSH Freshworks Inc.
Class A Common Stock
S - Sale -1,223 1,941,391 -0.06 37.91 -46,364 73,598,133
2021-11-23 2021-11-19 4 FRSH Freshworks Inc.
Class A Common Stock
S - Sale -5,760 2,095,523 -0.27 39.01 -224,698 81,746,352
2021-11-23 2021-11-19 4 FRSH Freshworks Inc.
Class A Common Stock
S - Sale -5,340 1,942,614 -0.27 39.01 -208,313 75,781,372
2021-11-23 2021-11-15 4/A FRSH Freshworks Inc.
Class B Common Stock
C - Conversion -2,152,069 5,264,086 -29.02
2021-11-23 2021-11-15 4/A FRSH Freshworks Inc.
Class B Common Stock
C - Conversion -1,995,035 0 -100.00
2021-11-23 2021-11-15 4/A FRSH Freshworks Inc.
Class A Common Stock
C - Conversion 2,152,069 2,152,069
2021-11-23 2021-11-15 4/A FRSH Freshworks Inc.
Class A Common Stock
C - Conversion 1,995,035 1,995,035
2021-11-18 2021-11-18 4 FRSH Freshworks Inc.
Class B Common Stock
C - Conversion -1,165 7,365,369 -0.02
2021-11-18 2021-11-18 4 FRSH Freshworks Inc.
Class B Common Stock
C - Conversion -1,080 1,947,954 -0.06
2021-11-18 2021-11-18 4 FRSH Freshworks Inc.
Class A Common Stock
S - Sale -1,165 0 -100.00 39.02 -45,458
2021-11-18 2021-11-18 4 FRSH Freshworks Inc.
Class A Common Stock
S - Sale -1,080 0 -100.00 39.02 -42,142
2021-11-18 2021-11-18 4 FRSH Freshworks Inc.
Class A Common Stock
C - Conversion 1,165 1,165
2021-11-18 2021-11-18 4 FRSH Freshworks Inc.
Class A Common Stock
C - Conversion 1,080 1,080
2021-11-18 2021-11-17 4 FRSH Freshworks Inc.
Class B Common Stock
C - Conversion -26,736 7,366,534 -0.36
2021-11-18 2021-11-17 4 FRSH Freshworks Inc.
Class B Common Stock
C - Conversion -24,786 1,949,034 -1.26
2021-11-18 2021-11-17 4 FRSH Freshworks Inc.
Class A Common Stock
S - Sale -26,736 0 -100.00 39.08 -1,044,843
2021-11-18 2021-11-17 4 FRSH Freshworks Inc.
Class A Common Stock
S - Sale -24,786 0 -100.00 39.08 -968,637
2021-11-18 2021-11-17 4 FRSH Freshworks Inc.
Class A Common Stock
C - Conversion 26,736 26,736
2021-11-18 2021-11-17 4 FRSH Freshworks Inc.
Class A Common Stock
C - Conversion 24,786 24,786
2021-11-18 2021-11-16 4 FRSH Freshworks Inc.
Class B Common Stock
C - Conversion -22,885 7,393,270 -0.31
2021-11-18 2021-11-16 4 FRSH Freshworks Inc.
Class B Common Stock
C - Conversion -21,215 1,973,820 -1.06
2021-11-18 2021-11-16 4 FRSH Freshworks Inc.
Class A Common Stock
S - Sale -22,885 0 -100.00 39.14 -895,719
2021-11-18 2021-11-16 4 FRSH Freshworks Inc.
Class A Common Stock
S - Sale -21,215 0 -100.00 39.14 -830,355
2021-11-18 2021-11-16 4 FRSH Freshworks Inc.
Class A Common Stock
C - Conversion 22,885 22,885
2021-11-18 2021-11-16 4 FRSH Freshworks Inc.
Class A Common Stock
C - Conversion 21,215 21,215
2021-09-24 2021-09-24 4 FRSH Freshworks Inc.
Class B Common Stock
C - Conversion 3,758,740 3,758,740
2021-09-24 2021-09-24 4 FRSH Freshworks Inc.
Class B Common Stock
C - Conversion 1,098,180 1,996,680 122.22
2021-09-24 2021-09-24 4 FRSH Freshworks Inc.
Class B Common Stock
C - Conversion 6,388,060 7,417,930 620.28
2021-09-24 2021-09-24 4 FRSH Freshworks Inc.
Class B Common Stock
C - Conversion 6,268,930 7,579,270 478.42
2021-09-24 2021-09-24 4 FRSH Freshworks Inc.
Series H Preferred Stock
C - Conversion -3,758,740 0 -100.00
2021-09-24 2021-09-24 4 FRSH Freshworks Inc.
Series G Preferred Stock
C - Conversion -1,098,180 0 -100.00
2021-09-24 2021-09-24 4 FRSH Freshworks Inc.
Series E Preferred Stock
C - Conversion -6,210,150 0 -100.00
2021-09-24 2021-09-24 4 FRSH Freshworks Inc.
Series D Preferred Stock
C - Conversion -6,388,060 0 -100.00
2021-09-24 2021-09-24 4 FRSH Freshworks Inc.
Series A Preferred Stock
C - Conversion -58,780 0 -100.00
2021-08-02 2021-07-30 4 DUOL Duolingo, Inc.
Class B Common Stock
C - Conversion 758,146 758,146
2021-08-02 2021-07-30 4 DUOL Duolingo, Inc.
Series F Preferred Stock
C - Conversion -758,146 0 -100.00
2021-08-02 2021-07-30 4 DUOL Duolingo, Inc.
Class B Common Stock
C - Conversion 1,112,941 1,112,941
2021-08-02 2021-07-30 4 DUOL Duolingo, Inc.
Series D Preferred Stock
C - Conversion -1,112,941 0 -100.00
2021-08-02 2021-07-30 4 DUOL Duolingo, Inc.
Class B Common Stock
C - Conversion -356,152 1,334,284 -21.07
2021-08-02 2021-07-30 4 DUOL Duolingo, Inc.
Class B Common Stock
C - Conversion 1,690,436 1,690,436
2021-08-02 2021-07-30 4 DUOL Duolingo, Inc.
Series D Preferred Stock
C - Conversion -1,690,436 0 -100.00
2021-08-02 2021-07-30 4 DUOL Duolingo, Inc.
Class A Common Stock
S - Sale -356,152 0 -100.00 102.00 -36,327,504
2021-08-02 2021-07-30 4 DUOL Duolingo, Inc.
Class A Common Stock
C - Conversion 356,152 356,152
2021-03-03 3 OSCR Oscar Health, Inc.
Class A Common Stock
21,344,748
2021-03-03 3 OSCR Oscar Health, Inc.
Class A Common Stock
1,705,944
2021-03-03 3 OSCR Oscar Health, Inc.
Class A Common Stock
255,092
2021-03-03 3 OSCR Oscar Health, Inc.
Class A Common Stock
481,988
2021-03-03 3 OSCR Oscar Health, Inc.
Class A Common Stock
255,092
2020-02-24 2020-02-20 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -82,488 1,137,641 -6.76
2020-02-24 2020-02-20 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -82,488 0 -100.00 65.38 -5,393,065
2020-02-24 2020-02-20 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 82,488 82,488
2020-02-19 2020-02-19 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -930,054 1,120,129 -45.36
2020-02-19 2020-02-19 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -844,358 0 -100.00 67.01 -56,580,430
2020-02-19 2020-02-19 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -85,696 844,358 -9.21 66.11 -5,665,363 55,820,507
2020-02-19 2020-02-19 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 930,054 930,054
2020-02-19 2020-02-18 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -382,696 2,150,183 -15.11
2020-02-19 2020-02-18 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -27,751 0 -100.00 66.04 -1,832,676
2020-02-19 2020-02-18 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -354,945 27,751 -92.75 65.67 -23,309,238 1,822,408
2020-02-19 2020-02-18 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 382,696 382,696
2020-02-19 2020-02-14 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -175,366 2,532,879 -6.48
2020-02-19 2020-02-14 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -175,366 0 -100.00 65.29 -11,449,646
2020-02-19 2020-02-14 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 175,366 175,366
2020-02-13 2020-02-13 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -830,211 2,708,245 -23.46
2020-02-13 2020-02-13 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -17,925 0 -100.00 66.07 -1,184,305
2020-02-13 2020-02-13 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -812,286 17,925 -97.84 65.52 -53,220,979 1,174,446
2020-02-13 2020-02-13 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 830,211 830,211
2020-02-13 2020-02-12 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -727,959 3,538,456 -17.06
2020-02-13 2020-02-12 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -727,959 0 -100.00 65.23 -47,484,766
2020-02-13 2020-02-12 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 727,959 727,959
2020-02-13 2020-02-11 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -282,589 4,266,415 -6.21
2020-02-13 2020-02-11 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -12,301 0 -100.00 66.06 -812,604
2020-02-13 2020-02-11 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -270,288 12,301 -95.65 65.27 -17,641,698 802,886
2020-02-13 2020-02-11 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 282,589 282,589
2020-02-06 2020-02-05 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -38,429 4,549,004 -0.84
2020-02-06 2020-02-05 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -1,000 0 -100.00 64.44 -64,440
2020-02-06 2020-02-05 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -37,429 1,000 -97.40 63.99 -2,395,082 63,990
2020-02-06 2020-02-05 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 38,429 38,429
2020-02-06 2020-02-04 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -242,124 4,587,433 -5.01
2020-02-06 2020-02-04 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -2,302 0 -100.00 64.29 -147,996
2020-02-06 2020-02-04 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -239,822 2,302 -99.05 63.64 -15,262,272 146,499
2020-02-06 2020-02-04 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 242,124 242,124
2020-01-24 2020-01-22 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -12,487 4,829,557 -0.26
2020-01-24 2020-01-22 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -12,487 0 -100.00 63.94 -798,419
2020-01-24 2020-01-22 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 12,487 12,487
2020-01-17 2020-01-16 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -169,973 4,842,044 -3.39
2020-01-17 2020-01-16 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -72,760 0 -100.00 62.21 -4,526,400
2020-01-17 2020-01-16 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -97,213 72,760 -57.19 61.55 -5,983,460 4,478,378
2020-01-17 2020-01-16 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 169,973 169,973
2020-01-17 2020-01-15 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -330,027 5,012,017 -6.18
2020-01-17 2020-01-15 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -330,027 0 -100.00 61.38 -20,257,057
2020-01-17 2020-01-15 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 330,027 330,027
2020-01-08 2020-01-06 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -2,085,172 5,342,044 -28.07
2020-01-08 2020-01-06 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -233,126 0 -100.00 53.27 -12,418,622
2020-01-08 2020-01-06 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -1,690,790 233,126 -87.88 52.58 -88,901,738 12,257,765
2020-01-08 2020-01-06 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -161,256 1,923,916 -7.73 51.72 -8,340,160 99,504,936
2020-01-08 2020-01-06 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 2,085,172 2,085,172
2020-01-03 2020-01-03 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -2,349,710 7,427,216 -24.03
2020-01-03 2020-01-03 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -1,441,224 0 -100.00 51.42 -74,107,738
2020-01-03 2020-01-03 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -908,486 1,441,224 -38.66 50.60 -45,969,392 72,925,934
2020-01-03 2020-01-03 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 2,349,710 2,349,710
2020-01-03 2020-01-02 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -371,081 9,776,926 -3.66
2020-01-03 2020-01-02 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -371,081 0 -100.00 50.26 -18,650,531
2020-01-03 2020-01-02 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 371,081 371,081
2020-01-03 2019-12-31 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -173,097 10,148,007 -1.68
2020-01-03 2019-12-31 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -173,097 0 -100.00 50.12 -8,675,622
2020-01-03 2019-12-31 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 173,097 173,097
2019-12-30 2019-12-29 4 CRCM Care.com Inc
Convertible Preferred Stock, Series A
J - Other 0 46,350 0.00
2019-12-30 2019-12-30 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -555,822 10,321,104 -5.11
2019-12-30 2019-12-30 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -555,822 0 -100.00 50.09 -27,841,124
2019-12-30 2019-12-30 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 555,822 555,822
2019-12-30 2019-12-27 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -8,826 10,876,926 -0.08
2019-12-30 2019-12-27 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -8,826 0 -100.00 50.22 -443,242
2019-12-30 2019-12-27 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 8,826 8,826
2019-12-30 2019-12-26 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -73,046 10,885,752 -0.67
2019-12-30 2019-12-26 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -73,046 0 -100.00 50.04 -3,655,222
2019-12-30 2019-12-26 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 73,046 73,046
2019-12-20 2019-12-19 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -17,832 10,958,798 -0.16
2019-12-20 2019-12-19 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale 0 0 50.18
2019-12-20 2019-12-19 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 17,832 17,832
2019-12-20 2019-12-18 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -1,018,275 10,976,630 -8.49
2019-12-20 2019-12-18 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale 0 0 50.03
2019-12-20 2019-12-18 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 1,018,275 1,018,275
2019-12-11 2019-12-10 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -2,262 11,994,905 -0.02
2019-12-11 2019-12-10 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -2,262 0 -100.00 50.01 -113,123
2019-12-11 2019-12-10 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 2,262 2,262
2019-12-11 2019-12-09 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion -144,877 11,997,167 -1.19
2019-12-11 2019-12-09 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
S - Sale -144,877 0 -100.00 50.33 -7,291,659
2019-12-11 2019-12-09 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
C - Conversion 144,877 144,877
2019-07-02 2019-06-29 4 CRCM Care.com Inc
Convertible Preferred Stock, Series A
J - Other 0 46,350 0.00
2019-06-18 2019-06-14 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion 1,457,959 20,275,670 7.75
2019-06-18 2019-06-14 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion 4,392,492 18,817,711 30.45
2019-06-18 2019-06-14 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion 2,052,996 14,425,219 16.59
2019-06-18 2019-06-14 4 CRWD CrowdStrike Holdings, Inc.
Class B Common Stock
C - Conversion 12,142,044 12,372,223 5,275.04
2019-06-18 2019-06-14 4 CRWD CrowdStrike Holdings, Inc.
Series E Redeemable Convertible Preferred Stock
C - Conversion -1,457,959 0 -100.00
2019-06-18 2019-06-14 4 CRWD CrowdStrike Holdings, Inc.
Series D-1 Redeemable Convertible Preferred Stock
C - Conversion -4,392,492 0 -100.00
2019-06-18 2019-06-14 4 CRWD CrowdStrike Holdings, Inc.
Series D Redeemable Convertible Preferred Stock
C - Conversion -2,052,996 0 -100.00
2019-06-18 2019-06-14 4 CRWD CrowdStrike Holdings, Inc.
Series C Redeemable Convertible Preferred Stock
C - Conversion -12,142,044 0 -100.00
2019-06-18 2019-06-14 4 CRWD CrowdStrike Holdings, Inc.
Class A Common Stock
P - Purchase 140,000 140,000 34.00 4,760,000 4,760,000
2018-12-31 2018-12-29 4 CRCM Care.com Inc
Convertible Preferred Stock, Series A
J - Other 0 46,350 0.00
2018-07-02 2018-06-29 4 CRCM Care.com Inc
Convertible Preferred Stock, Series A
J - Other 0 46,350 0.00
2018-06-27 2018-06-25 4 MGTA Magenta Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -8,494,864 0 -100.00
2018-06-27 2018-06-25 4 MGTA Magenta Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -133,400 0 -100.00
2018-06-27 2018-06-25 4 MGTA Magenta Therapeutics, Inc.
Common Stock
C - Conversion 3,339,137 3,339,137
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Series B Convertible Preferred Stock
C - Conversion -3,125,312 0 -100.00
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Common Stock
C - Conversion 3,125,312 3,125,312
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Series C Convertible Preferred Stock
C - Conversion -1,924,474 0 -100.00
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Common Stock
C - Conversion 1,924,474 1,924,474
2018-01-30 2018-01-30 4 ARMO ARMO BioSciences, Inc.
Series C Convertible Preferred Stock
C - Conversion -607,350 0 -100.00
2018-01-30 2018-01-30 4 ARMO ARMO BioSciences, Inc.
Common Stock
C - Conversion 607,350 607,350
2018-01-30 2018-01-30 4 ARMO ARMO BioSciences, Inc.
Series C-1 Convertible Preferred Stock
C - Conversion -607,350 0 -100.00
2018-01-30 2018-01-30 4 ARMO ARMO BioSciences, Inc.
Common Stock
C - Conversion 607,350 607,350
2018-01-02 2017-12-29 4 CRCM Care.com Inc
Convertible Preferred Stock, Series A
J - Other 0 46,350 0.00
2017-11-20 2017-11-20 4 ASNS Arsanis, Inc.
Series D Convertible Preferred Stock
C - Conversion -1,540,499 0 -100.00
2017-11-20 2017-11-20 4 ASNS Arsanis, Inc.
Common Stock
C - Conversion 451,362 451,362
2017-11-03 2017-11-01 4 CRCM Care.com Inc
Convertible Preferred Stock, Series A
J - Other 0 46,350 0.00
2017-06-30 2017-06-29 4 CRCM Care.com Inc
Convertible Preferred Stock, Series A
J - Other 0 46,350 0.00
2016-12-30 2016-12-29 4 CRCM Care.com Inc
Convertible Preferred Stock, Series A
J - Other 0 46,350 0.00
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)